Sort
11,323 grants matching “glioblastoma”
Small molecule inhibitors with a therapeutic window for EGFR signaling variants in glioblastoma
$177,362Michael J Eck · Brigham And Women'S Hospital · U19 · FY2024 · CA
Core 1: Biospecimen and Pathology Core
$177,356William H. Yong · University Of California Los Angeles · P50 · FY2017 · CA
Prevention of radiation-induced neurocognitive dysfunction by induced adult neural stem cell
$177,353Mihoko Kai · Johns Hopkins University · R21 · FY2016 · CA
Clinical and Translational Investigations of Immune Suppression and Immune Modulation in Glioblastoma
$177,113Edjah Nduom · National Institute Of Neurological Disorders And Stroke · ZIA · FY2021 · NS
The Role of Eph-ephrin Interactions in Glioma Migration
$177,053Peter D Canoll · Columbia University Health Sciences · K08 · FY2006 · NS
Novel role of the polycomb repressive complex PRC2/EZH2 in glioblastoma
$177,027Vishwanath R Iyer · University Of Texas At Austin · R21 · FY2016 · CA
The Role of Suppressor of Fused in Neural Stem Cells and its Implications in Tumorigenesis
$177,012Odessa Yabut · University Of California, San Francisco · K01 · FY2017 · CA
The Role of Suppressor of Fused in Neural Stem Cells and its Implications in Tumorigenesis
$177,012Odessa Yabut · University Of California, San Francisco · K01 · FY2016 · CA
Receptor Tyrosine Kinase/PTEN Interactions in Gliomas
$177,008University Of Virginia Charlottesville · R01 · FY2005 · NS
Gene Therapy for Glioma
$176,906Cedars-Sinai Medical Center · R21 · FY2004 · NS
Gene Therapy for Glioma
$176,906Cedars-Sinai Medical Center · R21 · FY2003 · NS
Role of m6A RNA methylation in Regulation of Translation in Human Glioblastoma
$176,654Nikolaos Tapinos · Rhode Island Hospital · R21 · FY2020 · CA
Evolution of cancer-specific molecular requirements for glioblastoma multiforme (
$176,645Patrick Paddison · Fred Hutchinson Cancer Research Center · R21 · FY2013 · CA
CD44 Antagonists in Targeted and Combinational Therapy for Glioblastoma
$176,526Qin Yu · Icahn School Of Medicine At Mount Sinai · R01 · FY2010 · CA
Developing a NF-κB/GADD45b targeting strategy for glioblastoma
$176,447Krishna Pl Bhat · University Of Tx Md Anderson Can Ctr · R21 · FY2020 · CA
BIOINFORMATICS
$176,407Max S. Wicha · University Of Michigan At Ann Arbor · P30 · FY2010 · CA
Targeting metabolic vulnerabilities in Astrocytoma, IDH-mutant, Grade 4
$176,218Tracy T Batchelor · Brigham And Women'S Hospital · U19 · FY2023 · CA
New Cancer Therapeutic Target
$176,175Michael J Spinella · Dartmouth College · R21 · FY2014 · CA
An engineered oncolytic herpes virus expressing a full-length α-CD47 mAb for the treatment of GBM
$176,146Behnam Badie · Beckman Research Institute/City Of Hope · U19 · FY2025 · CA
Augmented homologous recombination as a mechanism of acquired temozolomide resistance in glioblastoma
$176,131Sandeep Burma · Ut Southwestern Medical Center · R21 · FY2016 · CA
Core C - Clinical Trials
$176,102John M Buatti · University Of Iowa · P01 · FY2020 · CA
Core C - Clinical Trials
$176,102John M Buatti · University Of Iowa · P01 · FY2021 · CA
Targeting the neuronal microenvironment in glioblastoma
$176,101Michelle Monje-Deisseroth · Brigham And Women'S Hospital · U19 · FY2025 · CA
Migration of Human Neural Stem Cells In Vitro and In Vivo
$176,094Alfredo Quinones-Hinojosa · Johns Hopkins University · K08 · FY2010 · NS
Migration of Human Neural Stem Cells In Vitro and In Vivo
$176,094Alfredo Quinones-Hinojosa · Johns Hopkins University · K08 · FY2009 · NS